Executives On The Move: New Appointments At CureVac And Bellus
Ramzi Benamar joins Bellus Health as CFO while Antony Blanc becomes chief business officer and commercial officer of CureVac. New directors are appointed at Gilead Sciences and Johnson & Johnson.
You may also be interested in...
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.
Additional views from the virtual J.P. Morgan Healthcare Conference on ways the COVID-19 pandemic has affected business practices and lessons learned for the future.
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Viatris debuts; Chi-Med charts its own path; Novo takes another go at obesity; Sangamo moves forward with CAR-Treg; Intercept readies for resubmission; and ImmunoGen is relying on a safety advantage for its ADC.